Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry

BACKGROUND/OBJECTIVES: The COSMOS study was a phase 2a clinical trial that showed high cure rates of genotype 1 chronic hepatitis C (CHC) and a favorable side effect profile using a 12-week regimen of simeprevir + sofosbuvir (SIM + SOF). Given the small number of patients treated with the SIM + SOF...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepatol Int
Egile Nagusiak: Roytman, Marina, Ramkissoon, Resham, Wu, Christina, Hong, Leena, Trujillo, Ruby, Huddleston, Leslie, Poerzgen, Peter, Seto, Todd, Wong, Linda, Tsai, Naoky
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612775/
https://ncbi.nlm.nih.gov/pubmed/27026431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-016-9719-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak